3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists

J Med Chem. 1999 Dec 2;42(24):4981-5001. doi: 10.1021/jm9910021.

M G Russell ¹, V G Matassa, R R Pengilley, M B van Niel, B Sohal, A P Watt, L Hitzel, M S Beer, J A Stanton, H B Broughton, J L Castro

Affiliations

Affiliation

1 Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park, Eastwick Road, Harlow, Essex CM20 2QR, U.K.

PMID: 10585208 DOI: 10.1021/jm9910021

Abstract

Several 5-HT(1D/1B) receptor agonists are now entering the marketplace as treatments for migraine. This paper describes the development of selective h5-HT(1D) receptor agonists as potential antimigraine agents which may produce fewer side effects. A series of 3-[3-(piperidin-1-yl)propyl]indoles has been synthesized which has led to the identification of 80 (L-772,405), a high-affinity h5-HT(1D) receptor full agonist having 170-fold selectivity for h5-HT(1D) receptors over h5-HT(1B) receptors. L-772,405 also shows very good selectivity over a range of Other serotonin and nonserotonin receptors and has excellent bioavailability following subcutaneous administration in rats. It therefore constitutes a valuable tool to delineate the role of h5-HT(1D) receptors in migraine. Molecular modeling and physical properties have been utilized to postulate the binding conformation of these compounds in the receptor cavity.

Name
Email *

	Sorry, but the email address you supplied was invalid.